Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Salbutamol dry-powder inhalation - Acerus Pharmaceuticals

Next Previous
Drug Profile

Salbutamol dry-powder inhalation - Acerus Pharmaceuticals

Alternative Names: Albuterol dry-powder inhalation - Acerus Pharmaceuticals; Albuterol sulfate; Albuterol sulfate DPI; Albuterol sulfate DPI - Acerus Pharmaceuticals; Albuterol sulfate dry-powder inhalation - Acerus Pharmaceuticals; TBS-7

Latest Information Update: 23 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Trimel Biopharma
  • Developer Acerus Pharmaceuticals Corporation
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Phenols; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Asthma

Highest Development Phases

  • No development reported Asthma

Most Recent Events

  • 09 Mar 2018 Acerus withdraws a phase II trial in Asthma prior to enrolment in USA (NCT01252758)
  • 08 Sep 2015 Trimel Pharmaceuticals is now called Acerus Pharmaceuticals
  • 04 Mar 2015 Phase I development is ongoing in Canada

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top